GR1004012B - Once-a-day pharmaceutical composition containing brivudine - Google Patents
Once-a-day pharmaceutical composition containing brivudineInfo
- Publication number
- GR1004012B GR1004012B GR20010100322A GR2001100322A GR1004012B GR 1004012 B GR1004012 B GR 1004012B GR 20010100322 A GR20010100322 A GR 20010100322A GR 2001100322 A GR2001100322 A GR 2001100322A GR 1004012 B GR1004012 B GR 1004012B
- Authority
- GR
- Greece
- Prior art keywords
- once
- pharmaceutical composition
- composition containing
- brivudine
- day pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
here is disclosed the activity of brivudine once-a-day in acute herpes zoster infections and post-herpetic neuralgia and the compositions thereof.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001MI000009A ITMI20010009A1 (en) | 2001-01-03 | 2001-01-03 | PHARMACEUTICAL COMPOSITIONS CONTAINING BRIVUDINA FOR SINGLE DAILY ADMINISTRATION |
Publications (2)
Publication Number | Publication Date |
---|---|
GR20010100322A GR20010100322A (en) | 2002-10-08 |
GR1004012B true GR1004012B (en) | 2002-11-01 |
Family
ID=11446384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20010100322A GR1004012B (en) | 2001-01-03 | 2001-07-05 | Once-a-day pharmaceutical composition containing brivudine |
Country Status (20)
Country | Link |
---|---|
AT (1) | AT6141U1 (en) |
BE (1) | BE1014522A5 (en) |
CH (1) | CH695662A5 (en) |
CZ (1) | CZ20012464A3 (en) |
DK (1) | DK177084B1 (en) |
ES (1) | ES2192456B1 (en) |
FI (1) | FI20011446A (en) |
FR (1) | FR2818907B1 (en) |
GB (1) | GB2370771A (en) |
GR (1) | GR1004012B (en) |
HR (1) | HRPK20010345B3 (en) |
HU (1) | HUP0102816A3 (en) |
IE (1) | IE20010413A1 (en) |
IT (1) | ITMI20010009A1 (en) |
NL (1) | NL1018431C2 (en) |
PL (1) | PL348480A1 (en) |
PT (1) | PT102642B (en) |
SE (1) | SE0102309L (en) |
SK (1) | SK287043B6 (en) |
UA (1) | UA76402C2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2239527B1 (en) * | 2004-03-01 | 2006-11-16 | M. Cruz Fernandez Gonzalez | PHARMACOLOGICAL COMPOSITION OF TOPICAL USE FOR THE TREATMENT OF HERPES ZOSTER. |
CN113712928A (en) * | 2021-09-29 | 2021-11-30 | 重庆市力扬医药开发有限公司 | Brivudine drug absorbed through oral mucosa |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0104857A1 (en) * | 1982-09-28 | 1984-04-04 | Beecham Group Plc | Deoxyuridine compounds, methods for preparing them and their use in medicine |
IT1170232B (en) * | 1983-10-31 | 1987-06-03 | Anna Gioia Stendardi | THERAPEUTIC COMPOSITIONS WITH ANTI-VIRAL ACTIVITY |
US5446031A (en) * | 1991-04-24 | 1995-08-29 | Yamasa Shuyu Kabushiki Kaisha | 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives |
WO1997025989A1 (en) * | 1996-01-19 | 1997-07-24 | Glaxo Group Limited | Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application |
-
2001
- 2001-01-03 IT IT2001MI000009A patent/ITMI20010009A1/en unknown
- 2001-04-25 IE IE20010413A patent/IE20010413A1/en not_active IP Right Cessation
- 2001-05-01 GB GB0110682A patent/GB2370771A/en not_active Withdrawn
- 2001-05-11 HR HR20010345A patent/HRPK20010345B3/en not_active IP Right Cessation
- 2001-05-29 CH CH00987/01A patent/CH695662A5/en not_active IP Right Cessation
- 2001-06-28 SE SE0102309A patent/SE0102309L/en not_active Application Discontinuation
- 2001-06-29 FR FR0108596A patent/FR2818907B1/en not_active Expired - Lifetime
- 2001-06-29 DK DKPA200101019A patent/DK177084B1/en not_active IP Right Cessation
- 2001-07-02 NL NL1018431A patent/NL1018431C2/en not_active IP Right Cessation
- 2001-07-03 FI FI20011446A patent/FI20011446A/en not_active Application Discontinuation
- 2001-07-04 SK SK957-2001A patent/SK287043B6/en not_active IP Right Cessation
- 2001-07-04 BE BE2001/0452A patent/BE1014522A5/en not_active IP Right Cessation
- 2001-07-04 CZ CZ20012464A patent/CZ20012464A3/en unknown
- 2001-07-04 UA UA2001074658A patent/UA76402C2/en unknown
- 2001-07-05 PT PT102642A patent/PT102642B/en active IP Right Grant
- 2001-07-05 ES ES200101566A patent/ES2192456B1/en not_active Expired - Fee Related
- 2001-07-05 GR GR20010100322A patent/GR1004012B/en unknown
- 2001-07-05 HU HU0102816A patent/HUP0102816A3/en unknown
- 2001-07-05 PL PL01348480A patent/PL348480A1/en not_active Application Discontinuation
-
2002
- 2002-07-03 AT AT0805702U patent/AT6141U1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ITMI20010009A0 (en) | 2001-01-03 |
FR2818907B1 (en) | 2006-05-26 |
ES2192456A1 (en) | 2003-10-01 |
PT102642A (en) | 2002-07-31 |
PL348480A1 (en) | 2002-07-15 |
CZ20012464A3 (en) | 2002-08-14 |
DK177084B1 (en) | 2011-07-11 |
GB2370771A (en) | 2002-07-10 |
FI20011446A (en) | 2002-07-04 |
HRPK20010345B3 (en) | 2005-02-28 |
AT6141U1 (en) | 2003-05-26 |
DK200101019A (en) | 2002-07-04 |
CH695662A5 (en) | 2006-07-31 |
PT102642B (en) | 2003-06-30 |
SE0102309L (en) | 2002-07-04 |
IE20010413A1 (en) | 2003-04-16 |
UA76402C2 (en) | 2006-08-15 |
HUP0102816A2 (en) | 2002-10-28 |
FI20011446A0 (en) | 2001-07-03 |
GB0110682D0 (en) | 2001-06-20 |
HRP20010345A2 (en) | 2003-08-31 |
FR2818907A1 (en) | 2002-07-05 |
SE0102309D0 (en) | 2001-06-28 |
SK9572001A3 (en) | 2003-03-04 |
GR20010100322A (en) | 2002-10-08 |
HUP0102816A3 (en) | 2005-01-28 |
ES2192456B1 (en) | 2005-02-01 |
SK287043B6 (en) | 2009-10-07 |
HU0102816D0 (en) | 2001-09-28 |
ITMI20010009A1 (en) | 2002-07-03 |
BE1014522A5 (en) | 2003-12-02 |
NL1018431C2 (en) | 2002-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0500163A3 (en) | Pyrazolo [5,1-b]quinazoline derivatives and pharmaceutical compositions thereof as inhibitors of impdh enzyme | |
ITRM980103A0 (en) | USE OF BACTERIA EQUIPPED WITH ARGININE DEIMINASE TO INTRODUCE APOSTOSIS AND/OR REDUCE AN INFLAMMATORY REACTION AND PHARMACEUTICAL COMPOSITIONS | |
ATE263558T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING LIPASE INHIBITORS AND CHITOSAN | |
BR0101304B1 (en) | "polyolefin composition comprising a mixture of UV absorbers and use of a mixture of UV absorbers". | |
DE69907977D1 (en) | Pyrrolobenzodiazepine | |
HUP0200403A3 (en) | Pyrrolopyrimidines as protein kinase inhibitors, pharmaceutical compositions containing them and their use | |
GEP20033092B (en) | Purine Inhibitors of Cyclin Dependent Kinase 2 and Ik-Aa | |
RS49995B (en) | The use of dialkyl fumarates | |
ATE279200T1 (en) | ETHANOLATES OF AZITHROMYCIN, PRODUCTION PROCESS AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
ES2149276T3 (en) | IMIDAZO (4,5-C) PIRIDIN-4-AMINAS. | |
ES2161548T3 (en) | COMBINATION OF AN INHIBITOR OF ALDOSA REDUCTASA AND AN INHIBITOR OF GLUCOGENO FOSFORILASA. | |
BR0013081A (en) | Metalloproteinase-inhibiting pyrimidine-2,4,6-triones | |
BR0010220A (en) | Pyrimidinone compounds | |
ATE250602T1 (en) | PYRIMIDO(6,1-A)ISOCHINOLINONE DERIVATIVES | |
IL164022A0 (en) | Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same | |
AU2284299A (en) | Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions | |
ATE302746T1 (en) | AMORPHOUS NITRIC ESTERS AND THEREOF PHARMACEUTICAL COMPOSITIONS | |
AU9534398A (en) | Novel pharmaceutical composition | |
ATE401896T1 (en) | PHARMACEUTICAL COMPOSITIONS WITH TUMOR NECROSIS FACTOR AND 2-METHOXYESTRON-3-O-SULPHAMAT AS ESTRONE SULPHATASE INHIBITORS | |
CA2429639A1 (en) | Stable azithromycin monohydrate | |
AU2001236338A1 (en) | Carbon-reinforced polycarbonate-abs composition and articles made from same | |
ATE268175T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DECURSIN | |
GB9714274D0 (en) | Pharmaceutical composition | |
TR200101493T2 (en) | Eletriptan hydrobromide monohydrate | |
GR20010100322A (en) | Once-a-day pharmaceutical composition containing brivudine |